- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01672684
Phase I: At-Home Support for Rural Women Using Group Video Calling
At-Home Support for Rural Women Using Group Video Calling
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
PRIMARY OBJECTIVES:
I. To examine whether delivering at-home professionally-led breast cancer support using group video calling is feasible, acceptable and satisfactory for women in rural northern California.
II. To evaluate the feasibility of using on-line tools to recruit, screen, treat, and assess this population for a subsequent randomized clinical trial.
III. Assess whether the rate of recruitment of women in this region in this study using predominantly on-line means of recruitment can be improved over that of the previous study using predominantly face-to-face means of recruitment.
SECONDARY OBJECTIVES:
I. Estimate effect size changes in measures of quality of life (post-traumatic stress disorder symptoms, depression symptoms, perceived stress, and positive states of mind), satisfaction with social support, and self-efficacy for coping with cancer.
II. Prescribe sample size. III. Perform I and II for all of these outcomes.
OUTLINE: Participants are randomized to 1 of 2 treatment arms.
ARM I (experimental arm): Participants complete at-home group video calling sessions for 1 1/2 hours once weekly for 8 weeks.
ARM II (control arm): Participants receive an educational workbook journal.
After completion of study treatment, participants are followed up for 1 week.
Study Type
Enrollment (Actual)
Phase
- Phase 1
Contacts and Locations
Study Locations
-
-
California
-
Nevada City, California, United States, 95959
- Sierra Streams Institute
-
Stanford, California, United States, 94305
- Stanford University Cancer Institute
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- To be eligible for this study, the participant must have been diagnosed with breast cancer within the previous 5 years prior to study entry; individuals who have been diagnosed with any stage of breast cancer are eligible
- There are no limitations regarding allowable type and amount of prior therapy
- There are no race/ethnic restrictions
- There are no life expectancy restrictions
- Neither Eastern Cooperative Oncology Group (ECOG) nor Karnofsky performance status will be employed
- There are no requirements for organ and marrow function
- Ability to understand and the willingness to sign a written informed consent document; this will be assessed in the telephone screen conducted by Lisa Frankel as she will review each section of the consent form with the participant and ask if she has any questions about it; this telephone screen will have been approved by the Stanford University Institutional Review Board (IRB), and Lisa Frankel will conduct the interviews in a private location to ensure confidentiality
- Eligibility for this study requires that a woman be a resident of one of 27 rural counties in California (Alpine, Amador, Butte, Calaveras, Colusa, Del Norte, El Dorado, Glenn, Imperial, Inyo, Lake, Lassen, Madera, Mariposa, Modoc, Mono, Nevada, Placer, Plumas, Shasta, Sierra, Siskiyou, Sutter, Tehama, Trinity, Tuolumne, or Yuba, except we will not include women living within the following cities: Chico, Madera, Redding, Rocklin, Roseville or Yuba City, due to this study's more rural focus)
- Eligibility for this study requires that a woman has sufficient hearing to be able to engage in conversation over the phone
- Eligibility for this study requires that a woman has a private place available where she can access the internet
- Eligibility for this study requires that a woman is potentially available to meet at the day of the week and time of the day that the group intervention is scheduled â in the event that she is randomly assigned to receive the at-home group calling intervention
- Eligibility for this study requires that women have broadband or digital subscriber line (DSL) internet access
- Eligibility for this study requires that women have a computer with a webcam and either a microphone or a phone available to call into the video conference
Exclusion Criteria:
- There are no therapy restrictions
- There are no restrictions regarding use of other investigational agents
- There are no exclusion requirements due to co-morbid disease or incurrent illness
- Requirements regarding history of allergic reactions attributed to compounds of similar chemical or biologic composition to investigational agent or device are not applicable to this study
- There are no exclusion criteria relating to concomitant medications or substances that have the potential to affect the activity or pharmacokinetics of the study agent
- There are no other agent-specific exclusion criteria
- Pregnancy or nursing patients will not be excluded from the study
- Patients who are cancer survivors or those who are human immunodeficiency virus (HIV)-positive will not be excluded from the study
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Arm I (experimental arm)
Participants complete at-home group video calling sessions for 1 1/2 hours once weekly for 8 weeks.
|
Complete at-home group video calling support sessions
|
Active Comparator: Arm II (control arm)
Participants receive an educational workbook journal.
|
Receive an educational workbook journal
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Feasibility of the study protocol as determined primarily through qualitative analysis of the group sessions and the interview data
Time Frame: At 1 week post-intervention
|
The major criterion for determining feasibility is to determine whether we can recruit rural women with breast cancer more rapidly using predominantly on-line procedures in this study than in our previous study that predominantly used face-to-face procedures.
The qualitative data for determining the feasibility will be collected during the at-home group video calling sessions and from women's interviews conducted at the end of the study.
Will be assessed using mixed methods.
|
At 1 week post-intervention
|
Acceptability of the study protocol as determined primarily through qualitative analysis of the group sessions and the interview data
Time Frame: At 1 week post-intervention
|
The qualitative data for determining the acceptability will be collected during the at-home group video calling sessions and from women's interviews conducted at the end of the study.
Will be assessed using mixed methods.
|
At 1 week post-intervention
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Changes in quality of life (posttraumatic stress, depression symptoms, perceived stress, and positive states of mind)
Time Frame: From baseline to 1 week post-intervention
|
Treatment effect size will be estimated for each measure for the purpose of prescribing the sample size for a subsequent larger randomized clinical trial examining efficacy of the intervention.
Will be analyzed using generalized linear mixed models.
|
From baseline to 1 week post-intervention
|
Changes in satisfaction with social support
Time Frame: From baseline to 1 week post-intervention
|
Treatment effect size will be estimated for each measure for the purpose of prescribing the sample size for a subsequent larger randomized clinical trial examining efficacy of the intervention.
Will be analyzed using generalized linear mixed models.
|
From baseline to 1 week post-intervention
|
Changes in self-efficacy for coping with cancer
Time Frame: From baseline to 1 week post-intervention
|
Treatment effect size will be estimated for each measure for the purpose of prescribing the sample size for a subsequent larger randomized clinical trial examining efficacy of the intervention.
Will be analyzed using generalized linear mixed models.
|
From baseline to 1 week post-intervention
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Cheryl Koopman, Stanford University
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- BRSADJ0023
- NCI-2012-01357 (Registry Identifier: CTRP (Clinical Trial Reporting Program))
- 21349 (Other Identifier: Stanford University)
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Depression
-
ProgenaBiomeRecruitingDepression | Depression, Postpartum | Depression, Anxiety | Depression Moderate | Depression Severe | Clinical Depression | Depression in Remission | Depression, Endogenous | Depression ChronicUnited States
-
Washington University School of MedicineCompletedTreatment Resistant Depression | Late Life Depression | Geriatric Depression | Refractory Depression | Therapy-Resistant DepressionUnited States, Canada
-
Kintsugi Mindful Wellness, Inc.Sonar Strategies; Vituity PsychiatryRecruitingDepression | Depression Moderate | Depression Severe | Depression MildUnited States
-
University of California, San FranciscoRecruitingDepression Moderate | Depression Mild | Depression, TeenUnited States
-
University GhentUniversiteit Antwerpen; Janssen-Cilag Ltd.RecruitingDepression Moderate | Depression Severe | Depression MildBelgium
-
Baylor College of MedicineUniversity of TexasRecruitingDepression | Depression Moderate | Depression Severe | Suicide and Self-harm | Depression in Adolescence | Depression MildUnited States
-
University of Cape TownNational Institute of Mental Health (NIMH)CompletedPostpartum Depression | Clinical Depression | Moderate DepressionSouth Africa
-
Washington University School of MedicinePatient-Centered Outcomes Research Institute; National Institute of Mental...CompletedMajor Depressive Disorder | Treatment Resistant Depression | Treatment-Refractory Depression | Late Life Depression | Geriatric DepressionUnited States, Canada
-
Northern Illinois UniversityUniversity Autonoma de Santo DomingoTerminatedDepression Moderate | Depression MildUnited States, Dominican Republic
-
Gerbera Therapeutics, Inc.Not yet recruitingPostpartum Depression | Depression, Postpartum | Postnatal Depression | Post-partum Depression | Post-Natal DepressionUnited States
Clinical Trials on support group therapy
-
University of North Carolina, Chapel HillNational Institute of Mental Health (NIMH)Completed
-
Nanjing Medical UniversityUnknown
-
National University Hospital, SingaporeNational University Cancer Institute, Singapore (NCIS)UnknownThe Effect of a Psycho-education Support Group TherapySingapore
-
Dokuz Eylul UniversityThe Scientific and Technological Research Council of TurkeyRecruiting
-
Dr Sébastien GrenierUniversité de Montréal; Alzheimer Society of CanadaCompletedAlzheimer DiseaseCanada
-
University of California, San FranciscoPatient-Centered Outcomes Research InstituteCompleted
-
Université Libre de BruxellesJules Bordet InstituteCompleted
-
Chinese University of Hong KongCompleted
-
Veterans Medical Research FoundationNational Institute of Mental Health (NIMH)UnknownPsychotic Disorders | SchizophreniaUnited States
-
Université de Reims Champagne-ArdenneCompletedDomestic ViolenceFrance